期刊文献+

脑梗塞患者血清中β淀粉样蛋白的含量及其临床意义 被引量:4

Levels and clinicalsignificance ofserum am yloid β-protein in cerebralinfarction
暂未订购
导出
摘要 目的:探讨脑梗塞(CI)患者血清β淀粉样蛋白(Aβ)水平及其在脑梗塞发生、发展中的关系。方法:采用放射免疫分析法测定30例急性脑梗塞患者(CI组)3~5d、10~14d以及30例正常人(对照组)血清Aβ水平,并测定CI组脑梗塞的体积及患者肢体残损程度。结果:CI组患者发病3~5d血清Aβ水平显著高于发病后10~14d眼(1.2460±0.2517)ng/mlvs(1.1103±0.1825)ng/ml,P<0.05演;10~14d血清Aβ水平明显高于正常对照组眼(1.1103±0.1825)ng/mlvs(0.9885±0.2253)ng/ml,P<0.05演。血清Aβ水平与患者脑梗塞灶的体积及神经功能缺损程度呈正相关(r=0.406,P<0.01)。结论:Aβ参与CI的发生与发展。干扰Aβ的产生,下调其表达,可减轻缺血性脑梗塞及所致的躯体神经功能缺损程度。 O bjective:To study the levels ofserum am yloid β-protein(A β)in cerebralinfarction(CI) and the effectofA β on the occurrence and developm entofCI.M ethods:The levels ofserum A β were de-tected by radioim m unoassay in 30patients with CI within 3~5days and 10~14days after attack and in 30 norm alcontrols)the volum e ofinfarcts with CI and the degree ofdeficiency ofthe extrem ities were detected as well.R esults:The levels ofserum A β of 3~5days after attack were significanthigher than those of10~ 14days [ (1.2460±0.2517 ) ng/m lvs ( 1.1103±0.1825 ) ng/m l, P <0.05 ] .The levels ofserum A β of10~14days were higher than those ofnorm alcontrols [ (1.1103±0.1825 ) ng/m lvs ( 0.9885±0.2253 ) ng/m l,P <0.05 ] .The levels ofserum A β ofpatients with CI were positively correlated with the volum e ofinfarcts as wellas the degree ofdeficiency ofthe nervous system ( r =0.406, P <0.01).C onclusion:A β is involved in the occurrence and developm entofCI.W e The degree ofdeficiency ofsom atic and nervous function caused by ischem ic CI can be alleviated by interfered with its production and expression.
出处 《山东大学学报(医学版)》 CAS 北大核心 2005年第4期353-355,共3页 Journal of Shandong University:Health Sciences
关键词 脑梗塞 Β淀粉样蛋白 血清 Cerebralinfarction)Am yloid β-protein)Serum
  • 相关文献

参考文献8

  • 1Koistinaho M, Kettunen MI, Holtzman DM, et al. Expression of human apolipoprotein E downregulates amyloid precursor protein-induced ischemic susceptibility[J].Stroke, 2002, 33(7):1 905-1 910.
  • 2Koistinaho J, Pyykonen I, Keinanen R, et al. Expression of beta-amyloid precursor protein mRNAs following transient focal ischemia[J]. Neuroreport, 1996, 7115:2 727.
  • 3Thal DR, Ghebremedhin E, Rub U, et al. Two types of sporadic cerebral amyloid angiopathy [J]. Neuropathol Exp Neurol, 2002, 61(3):282-293.
  • 4Allen JS, Murphy GM, Eng LF, et al. Alzheimer's disease: β- amyloid precursor protein mRNA expression in mononuclear blood cells[J]. Neuroscilett, 1991, 132:109-112.
  • 5Monning R, Konig G, Banati RB, et al. Alzheimer betaamyloid protein precursor in immunocompeyent cells[J].Biol Chem, 1992, 267:23 950-23 956.
  • 6Weller RO, Rreston SD. The spectrum of vascular disease in dementia from ischemia to amyloid angiopathy[J]. Adv Exp Med Biol, 2001, 487(2):111-122.
  • 7Yah SD, Chen X, Fu J, et al. RAGE and beta peptideneurotoxicity in Alzheimer's disease [J]. Nature, 1996,382:685-691.
  • 8Crawford F, Suo I, Fang C, et al. Characteristics of the in vitro vasoactivity of beta-amyloid peptide [J]. Exp Neurol, 1998, 150:159-168.

同被引文献49

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部